Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Sulindac exhibits anti-proliferative and anti-invasive effects in uterine serous carcinoma cells

Journal of Cancer Research and Clinical Oncology(2024)10.1007/s00432-024-05926-9Source: DataRank Database

Sulindac exhibits anti-proliferative and anti-invasive effects in uterine serous carcinoma cells is a research paper published in Journal of Cancer Research and Clinical Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.66)OA: goldTopics (40)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Weimin Kong ORCID,Xiaochang Shen,Boer Deng ORCID,Jennifer Haag,Nikita Sinha ORCID

Live enrichment

PubMed:39198302 PMC:PMC11358172 OpenAlex:https://openalex.org/W4401943070

NIH/NCI

Grant: NIH/NCI - R37CA226969

NCI NIH HHS

Grant: R37 CA226969

NIEHS NIH HHS

Grant: P30 ES010126

National Institutes of Health

Grant: 5R37CA226969-05

Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer

FWCI

0.66

Citation Percentile

0.7%

Citation Trend

2025

goldLicense: cc-by-nc-nd

journalhttps://link.springer.com/content/pdf/10.1007/s00432-024-05926-9.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s00432-024-05926-9.pdf

publisherhttps://link.springer.com/article/10.1007/s00432-024-05926-9/fulltext.html

journalhttp://dx.doi.org/10.1007/s00432-024-05926-9

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39198302

Fields of Study

Pharmacological Effects of Medicinal PlantsInflammatory mediators and NSAID effectsEstrogen and related hormone effects03 medical and health sciences0302 clinical medicine

MeSH Terms

Cell AdhesionCell SurvivalFemaleHumansNeoplasm InvasivenessSulindacUterine NeoplasmsApoptosisCystadenocarcinoma, SerousCell Line, TumorCell Proliferation

Keywords

SulindacHematologySerous carcinomaInternal medicineMedicineSerous fluidCarcinomaCancer researchCancerOvarian cancerCell proliferationInvasionCOX-2Uterine Serous CarcinomaCell SurvivalResearchApoptosisCystadenocarcinoma, SerousCell Line, TumorUterine NeoplasmsCell AdhesionHumansFemaleNeoplasm Invasiveness

Sustainable Development Goals

SDG 0: Zero hunger